Investor Newsletter - December 2023


Amplia has published its latest Investor Newsletter today.

This edition includes an update on key milestones from the ACCENT trial, including plans to expand into South Korea; a recap of the promising ovarian cancer data from collaborators in San Diego; and a snapshot into the work of CMC Project Manager, Adrian Sulistio.

Click here to read the newsletter.